Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

Ad­vi­sors to the FDA had dif­fi­cul­ty dis­sect­ing a small but con­cern­ing set of safe­ty da­ta from Mod­er­na’s pe­di­atric RSV vac­cine da­ta, large­ly con­clud­ing that oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.